| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 156, Issue 11 4137-4145, Copyright © 1996 by American Association of Immunologists
ARTICLES |
MP Matousek, JG Nedrud and CV Harding
Institute of Pathology, Case Western Reserve University, Cleveland, Ohio 44106, USA.
Cholera toxin (CT) is a potent mucosal adjuvant with enhancing effects on Ag presentation, although the mechanisms of its adjuvanticity remain poorly understood. Using an in vitro Ag presentation assay, we found CT and recombinant B subunit (rCTB) to have distinct effects on different stages of processing and class II MHC (MHC-II)-restricted presentation of hen egg lysozyme (HEL). CT treatment of macrophages resulted in enhanced presentation of soluble HEL(48-61) peptide to3A9 hybridoma cells. However, CT had inhibitory effects on intracellular processing of soluble native Ag. Thus, CT inhibited presentation when added prior to HEL, whereas presentation was enhanced when CT was added after HEL exposure and the generation of peptide-MHC-II complexes. Pretreatment of macrophages with CT also markedly inhibited phagocytic processing of a Crl-HEL fusion protein (containing the HEL(48-61) epitope) expressed in intact bacteria (Escherichia coli HB101.Crl-HEL or Salmonella typhimurium 14028s.Crl-HEL), whereas addition of CT to macrophages after a 2-h incubation with the bacteria again enhanced presentation. CT produced little effect on overall uptake and catabolism of radiolabeled HEL or HB101.Crl-HEL. In contrast to the holotoxin, purified rCTB subunit did not inhibit intracellular processing of soluble or bacterial Ag, although it similarly enhanced the presentation of surface HEL-(48-61)-I-Ak complexes to 3A9 cells. These data suggest that the inhibitory effects of CT on Ag processing are mediated by the A subunit.
This article has been cited by other articles:
|
|
 |
|
  G. Hajishengallis, S. Arce, C.M. Gockel, T.D. Connell, and M.W. Russell Immunomodulation with Enterotoxins for the Generation of Secretory Immunity or Tolerance: Applications for Oral Infections J. Dent. Res., December 1, 2005; 84(12): 1104 - 1116. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. K. Rouquette-Jazdanian, A. Foussat, L. Lamy, C. Pelassy, P. Lagadec, J.-P. Breittmayer, and C. Aussel Cholera Toxin B-Subunit Prevents Activation and Proliferation of Human CD4+ T Cells by Activation of a Neutral Sphingomyelinase in Lipid Rafts J. Immunol., November 1, 2005; 175(9): 5637 - 5648. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Castagliuolo, M. Sardina, P. Brun, C. DeRos, C. Mastrotto, L. Lovato, and G. Palu Clostridium difficile Toxin A Carboxyl-Terminus Peptide Lacking ADP-Ribosyltransferase Activity Acts as a Mucosal Adjuvant Infect. Immun., May 1, 2004; 72(5): 2827 - 2836. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Fraser, L. de Haan, A. R. Hearn, H. K. Bone, R. J. Salmond, A. J. Rivett, N. A. Williams, and T. R. Hirst Mutant Escherichia coli Heat-Labile Toxin B Subunit That Separates Toxoid-Mediated Signaling and Immunomodulatory Action from Trafficking and Delivery Functions Infect. Immun., March 1, 2003; 71(3): 1527 - 1537. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Soriani, L. Bailey, and T. R. Hirst Contribution of the ADP-ribosylating and receptor-binding properties of cholera-like enterotoxins in modulating cytokine secretion by human intestinal epithelial cells Microbiology, March 1, 2002; 148(3): 667 - 676. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. G. Millar, T. R. Hirst, and D. P. Snider Escherichia coli Heat-Labile Enterotoxin B Subunit Is a More Potent Mucosal Adjuvant than Its Closely Related Homologue, the B Subunit of Cholera Toxin Infect. Immun., May 1, 2001; 69(5): 3476 - 3482. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. O. Nashar, Z. E. Betteridge, and R. N. Mitchell Evidence for a role of ganglioside GM1 in antigen presentation: binding enhances presentation of Escherichia coli enterotoxin B subunit (EtxB) to CD4+ T cells Int. Immunol., April 1, 2001; 13(4): 541 - 551. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Yamamoto, H. Kiyono, S. Yamamoto, E. Batanero, M.-N. Kweon, S. Otake, M. Azuma, Y. Takeda, and J. R. McGhee Direct Effects on Antigen-Presenting Cells and T Lymphocytes Explain the Adjuvanticity of a Nontoxic Cholera Toxin Mutant J. Immunol., June 15, 1999; 162(12): 7015 - 7021. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Braun, J. He, C.-Y. Wu, and B. L. Kelsall Cholera Toxin Suppresses Interleukin (IL)-12 Production and IL-12 Receptor beta 1 and beta 2 Chain Expression J. Exp. Med., February 1, 1999; 189(3): 541 - 552. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Harokopakis, G. Hajishengallis, and S. M. Michalek Effectiveness of Liposomes Possessing Surface-Linked Recombinant B Subunit of Cholera Toxin as an Oral Antigen Delivery System Infect. Immun., September 1, 1998; 66(9): 4299 - 4304. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Matousek, J. G. Nedrud, W. Cieplak Jr., and C. V. Harding Inhibition of Class II Major Histocompatibility Complex Antigen Processing by Escherichia coli Heat-Labile Enterotoxin Requires an Enzymatically Active A Subunit Infect. Immun., July 1, 1998; 66(7): 3480 - 3484. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
